Cargando…

Pretreatment of breast cancer cells with doxorubicin facilitates the subsequent uptake of zoledronic acid

Detalles Bibliográficos
Autores principales:	Lefley, DV, Holen, I, Coleman, RE, Ottewell, PD
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300783/ http://dx.doi.org/10.1186/bcr1964

Ejemplares similares

Mechanisms of apoptosis and cell-cycle arrest in subcutaneous breast tumours treated sequentially with doxorubicin followed by zoledronic acid
por: Ottewell, PD, et al.
Publicado: (2008)

Synergistic effects of cytotoxic drugs and antiresorptive agents in vitro and in vivo
por: Ottewell, PD, et al.
Publicado: (2006)

The differential anti-tumour effects of zoledronic acid in breast cancer – evidence for a role of the activin signaling pathway
por: Wilson, Caroline, et al.
Publicado: (2015)

The kinetochore protein Cenp-F is a potential novel target for zoledronic acid in breast cancer cells
por: Brown, Hannah K, et al.
Publicado: (2011)

IL-1 drives breast cancer growth and bone metastasis in vivo
por: Holen, Ingunn, et al.
Publicado: (2016)

A single administration of combination therapy inhibits breast tumour progression in bone and modifies both osteoblasts and osteoclasts
por: Brown, H.K., et al.
Publicado: (2012)

Effects of combined treatment with Zometa and Taxol on endothelial cells in vitro
por: Michailidou, M, et al.
Publicado: (2006)

Six monthly intravenous zoledronic acid in childhood osteoporosis
por: Munns, CF, et al.
Publicado: (2013)

Oestradiol Contributes to Differential Antitumour Effects of Adjuvant Zoledronic Acid Observed Between Pre- and Post-Menopausal Women
por: Canuas-Landero, Victor G., et al.
Publicado: (2021)

Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction
por: Neville-Webbe, H L, et al.
Publicado: (2010)

Synergy between liposomal zoledronic acid and γδ T-cells in the treatment of epithelial ovarian cancer
por: Pereira, Ana Catarina Parente, et al.
Publicado: (2013)

Quantification of the UK five-point breast imaging classification and mapping to BI-RADS: to facilitate comparison of reporting, research and published literature
por: Taylor, K, et al.
Publicado: (2011)

Zoledronic acid protects from local and systemic bone loss in tumor necrosis factor-mediated arthritis
por: Redlich, K, et al.
Publicado: (2004)

Loss of plakoglobin promotes decreased cell-cell contact, increased invasion, and breast cancer cell dissemination in vivo
por: Holen, Ingunn, et al.
Publicado: (2012)

Erratum to: Loss of plakoglobin promotes cell-cell contact, increased invasion and breast cancer cell dissemination in vivo
por: Holen, Ingunn, et al.
Publicado: (2017)

Benefits of combined treatments using antiresorptive agents and cytotoxic drugs
por: Holen, I, et al.
Publicado: (2006)

Modifying the osteoblastic niche with zoledronic acid in vivo—Potential implications for breast cancer bone metastasis
por: Haider, Marie-Therese, et al.
Publicado: (2014)

Is pretreatment assessment of the contralateral breast with MRI useful following a new diagnosis of invasive lobular cancer?
por: Russell, Harriet, et al.
Publicado: (2015)

Developing a prediction model for benefit from fulvestrant in heavily pretreated metastatic breast cancer patients
por: Amir, E, et al.
Publicado: (2009)

Targeting Asian women results in greater uptake for breast screening
por: Gillespie, P
Publicado: (2006)

Use of health promotion to improve uptake in breast screening in Northamptonshire
por: True, R, et al.
Publicado: (2006)

Ultrasound breast imaging versus pathology; correlation of reported benign ultrasound scans with subsequent biopsy
por: Sinclair, M
Publicado: (2006)

Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions
por: George, Christopher N., et al.
Publicado: (2020)

PB.22. Does mammographic compression force at breast screening influence the likelihood of subsequent screening attendance?
por: Meyer, J, et al.
Publicado: (2014)

Axillary ultrasound in staging breast cancer: diagnostic accuracy and effect on subsequent axillary surgery - the Plymouth experience
por: Hall, SJ, et al.
Publicado: (2009)

A TRAIL-R1-specific ligand in combination with doxorubicin selectively targets primary breast tumour cells for apoptosis
por: Twiddy, D, et al.
Publicado: (2010)

A phase II randomized trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC)
por: Bensalem, A, et al.
Publicado: (2005)

Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells
por: Ubellacker, Jessalyn M., et al.
Publicado: (2017)

Development of clinically relevant in vivo metastasis models using human bone discs and breast cancer patient-derived xenografts
por: Lefley, Diane, et al.
Publicado: (2019)

GLUT expression and 18F-FDG uptake in breast cancer cell lines
por: Abrantes, Ana M, et al.
Publicado: (2010)

Immunostimulatory effects on B cells by the chemotherapeutic drug Doxorubicin
por: Kinn, Johan M, et al.
Publicado: (2011)

Doxorubicin leads to impaired insulin signaling in skeletal muscle
por: Alves de Lima, Edson, et al.
Publicado: (2014)

Adipose tissue homeostasis is deeply disrupted by doxorubicin treatment
por: Batatinha, Helena, et al.
Publicado: (2014)

Prospective Study of Outcome in Sporadic versus Hereditary Breast Cancer: pros and cons of running a cohort study
por: Gerty, SM, et al.
Publicado: (2008)

Impact of index of multiple deprivation and ethnicity on breast screening uptake in the North West of England
por: Bhola, Jayeshwaraj, et al.
Publicado: (2015)

Can digital breast tomosynthesis offer an alternative to MRI in preoperative imaging of lobular carcinoma?
por: Wall, PD, et al.
Publicado: (2011)

The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasis
por: Hadji, P., et al.
Publicado: (2012)

Cyclo-oxygenase-2 expression is associated with poor clinical outcome after doxorubicin-based chemotherapy in node-positive breast cancer: integration of tissue microarray
por: Han, SH, et al.
Publicado: (2005)

Probiotic pretreatment improves survival and prevents gut mucosal barrier dysfunction in sepsis
por: Calisto, KL, et al.
Publicado: (2014)

Appropriate fluid resuscitation of septic shock patients pretreated with high doses of catecholamines
por: Lewejohann, JC, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jiap5g5a18co7sml98f5r1acd8